Tegaserod Clinical Trials

• The Effects of Tegaserod Vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia
  ClinicalTrials.gov Identifier: NCT00277550 - Not yet recruiting
  Constipation and Dyspepsia
  
• Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method
  ClinicalTrials.gov Identifier: NCT00563615 - Recruiting
  Constipation
  
• An Evaluation of the Efficacy and Safety of Tegaserod 6 Mg Bid Given Orally to Chinese Patients with Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00139568 - Completed
  Chronic constipation
  
• Assessment of Efficacy and Safety of Tegaserod in Male Patients with Chronic Constipation.
  ClinicalTrials.gov Identifier: NCT00141089 - Completed
  Chronic Constipation
  
• Efficacy, Safety and Tolerability of Tegaserod in Patients with Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00149877 - Completed
  Chronic Constipation
  
• Efficacy of Tegaserod in Relieving the Symptoms of Female Patients with Irritable Bowel Syndrome (IBS), Excluding Those with Predominant Diarrhea IBS
  ClinicalTrials.gov Identifier: NCT00142987 - Completed
  IBS-C and IBS with mixed bowel habits
  
• A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination with Omeprazole Given Orally in Patients with Symptoms of Symptomatic Gastroespohageal Reflux Disease (sGERD)
  ClinicalTrials.gov Identifier: NCT00149851 - Completed
  symptomatic gastroespohageal reflux disease
  
• The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
  ClinicalTrials.gov Identifier: NCT00171470 - Completed
  Dyspepsia
  
• Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
  ClinicalTrials.gov Identifier: NCT00232024 - Completed
  Dyspepsia
  
• Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
  ClinicalTrials.gov Identifier: NCT00232089 - Completed
  Dyspepsia
  
• Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
  ClinicalTrials.gov Identifier: NCT00232037 - Completed
  Dyspepsia
  
• Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
  ClinicalTrials.gov Identifier: NCT00232102 - Completed
  Dyspepsia
  
• Preference of Tegaserod Vs. PEG 3350 in Patients With Constipation
  ClinicalTrials.gov Identifier: NCT00171522 - Completed
  Constipation
  
• Assessment of the Effect of Tegaserod (2 Mg Tid and 6 Mg Tid) on Dyspeptic Symptoms in Diabetic Patients with Symptoms of Diabethic Gastropathy
  ClinicalTrials.gov Identifier: NCT00142974 - Terminated
  Diabetic Gastropathy
  
• The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
  ClinicalTrials.gov Identifier: NCT00171457 - Completed
  Heartburn; Dyspepsia
  
• Polyethyleneglycol3350 Vs Tegaserod in Treatment of Patients with Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00153140 - Completed
  Constipation
  
• Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
  ClinicalTrials.gov Identifier: NCT00171418 - Completed
  Gastroesophageal Reflux Disease (GERD)
  
• Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
  ClinicalTrials.gov Identifier: NCT00171483 - Completed
  Gastroesophageal Reflux Disease (GERD)
  
• Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
  ClinicalTrials.gov Identifier: NCT00390975 - Terminated
  Gastroparesis; Diabetes
  
• Efficacy and Safety of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain
  ClinicalTrials.gov Identifier: NCT00365820 - Terminated
  Constipation
  
• Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
  ClinicalTrials.gov Identifier: NCT00348634 - Terminated
  Chronic Constipation
  
• A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00563758 - Terminated
  Constipation; Chronic Disease
  
• Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
  ClinicalTrials.gov Identifier: NCT00399659 - Terminated
  Opioid-Induced Constipation
  
• Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
  ClinicalTrials.gov Identifier: NCT00414024 - Terminated
  Opioid-Induced Constipation
  
• The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00171431 - Terminated
  Constipation Predominant - Irritable Bowel Syndrome (IBS-C)